COVID-19: Waiting For The Worst

0
COVID-19: Waiting For The Worst
Screen capture from The U.S. COVID-19 Tracker via Infection2020.com
COVID-19 tracker
Screen capture from The U.S. COVID-19 Tracker via Infection2020.com

COVID-19 Tracker: Waiting For The Worst

I should be writing more. That’s what I tell myself. I developed a system that generated decent returns for risk-averse investors during the bull market, and limited their declines (and, in some cases, even generated positive returns) during the bear market. And I warned readers to hedge coronavirus risk before the crash. So I should be doing a better job of capitalizing on that.

Get The Full Series in PDF

Get the entire 10-part series on Charlie Munger in PDF. Save it to your desktop, read it on your tablet, or email to your colleagues.

Q4 2019 hedge fund letters, conferences and more

Instead, I keep refreshing that COVID-19 tracker above, as I sit here in the contagion hot zone of Bergen County, NJ. I put on a surgical mask and gloves for occasional trips to buy food or medicine or whatever home exercise equipment is left, and then I go home and look at that site. The 24-hour increase in deaths dropped to 14% on Sunday, for the first time since I'd discovered the site about a week ago, and I was briefly encouraged. But as I write this, it's back up to 26%. If it stays at that level, and deaths peak in two weeks, by that time there could be more than 80,000 deaths in the U.S. Grim, but it could be a lot worse if so many of us weren't on lock down right now.

EXCLUSIVE: Lee Ainslie’s Maverick Had A Challenging 2Q

Maverick USA was down 3.3% for the second quarter, while Maverick Levered was down 2.1%. Maverick Long Enhanced was up 8%. Year to date, Maverick USA is up 31.8%, while Maverick Levered has gained 49.3%. Maverick Long Enhanced has returned 9.9% for the first six months of the year. Maverick Capital is a long/ short Read More


Looking Ahead

Markets are supposed to be forward-looking, so with the SPDR S&P 500 ETF (SPY) up more than 17%, as of Monday's close, from the bottom, one might assume the market is looking past the peak in COVID-19 deaths expected next month.

COVID-19 tracker

But as my Twitter correspondent James Miller, the Smith College economist, noted, markets weren't very forward looking in early February.

COVID 19 tracker: What Now?

So what now? I wrote recently that it was too late to hedge market risk because it was too expensive, but it might get a little cheaper after a bounce. We've had a bounce and it's gotten a little cheaper, but it's still extremely expensive: 11.61% of position value annualized, to protect against a >20% decline in SPY over the next ~6 months.

Covid

By way of comparison, when I suggested hedging on February 13th, the annualized cost of similar protection was about 1.12% of position value.

Later, I wrote about going on offense, with a hedged bet on the  ProShares UltraShort Oil & Gas ETF (DUG), but as of this writing, the hedging cost isn't as attractive so that's no longer one of Portfolio Armor's top names.

What about one of Portfolio Armor's current top names? The top ten names as of Monday's close are mostly short-duration government bond and currency ETFs, so not a lot of upside potential.

The bounce since the market bottom seems to have put Portfolio Armor's security selection in a conservative mode. Those top names are updated every day the market's open, so I would keep an eye on them, and when their potential returns go up - whether because it's picking stocks in a bullish scenario, or inverse ETFs in a bearish one - that's when I'd consider putting more money to work (while hedged, of course).

No posts to display